HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wende Li Selected Research

chaetocin

1/2021ROS/JNK/C-Jun Pathway is Involved in Chaetocin Induced Colorectal Cancer Cells Apoptosis and Macrophage Phagocytosis Enhancement.
10/2019ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wende Li Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 01/2007
4Alzheimer Disease (Alzheimer's Disease)
04/2019 - 01/2007
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2020
3Carcinogenesis
01/2020 - 08/2019
2Breast Neoplasms (Breast Cancer)
03/2021 - 06/2014
2Neoplasm Metastasis (Metastasis)
03/2021 - 01/2017
2Brain Neoplasms (Brain Tumor)
01/2018 - 09/2017
2Glioblastoma (Glioblastoma Multiforme)
01/2018 - 09/2017
2Stomach Neoplasms (Stomach Cancer)
01/2018 - 01/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2014 - 09/2010
1Nausea
01/2022
1Hypoxia (Hypoxemia)
03/2021
1Disease Progression
03/2021
1Colitis
10/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2020
1Reperfusion Injury
10/2019
1Inflammation (Inflammations)
09/2019
1Neuroinflammatory Diseases
09/2019
1Lung Neoplasms (Lung Cancer)
08/2019
1Amyloid Plaque
04/2019
1Phyllodes Tumor (Cystosarcoma Phylloides)
01/2019
1Bites and Stings (Sting)
01/2019
1Stroke (Strokes)
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017
1Body Weight (Weight, Body)
08/2014

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
01/2019 - 06/2014
2Therapeutic UsesIBA
01/2022 - 01/2022
2AntigensIBA
01/2022 - 12/2011
2Messenger RNA (mRNA)IBA
01/2022 - 01/2020
2chaetocinIBA
01/2021 - 10/2019
2CateninsIBA
01/2020 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2017
2Thioredoxin-Disulfide ReductaseIBA
10/2019 - 09/2019
2CytokinesIBA
09/2019 - 02/2012
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2019 - 10/2016
2AntibodiesIBA
01/2019 - 12/2011
2Biological ProductsIBA
09/2018 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 10/2014
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2018 - 10/2014
2PhytochemicalsIBA
09/2017 - 01/2007
2MicroRNAs (MicroRNA)IBA
09/2017 - 01/2017
2Proteins (Proteins, Gene)FDA Link
01/2017 - 12/2011
1CannabinoidsIBA
01/2022
1Small Cytoplasmic RNAIBA
01/2022
1VaccinesIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Neoplasm Antigens (Tumor Antigens)IBA
01/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022
1Dronabinol (THC)FDA LinkGeneric
01/2022
1Losartan (Cozaar)FDA LinkGeneric
03/2021
1Angiotensin Receptor AntagonistsIBA
03/2021
1pimonidazoleIBA
03/2021
1Diacylglycerol KinaseIBA
01/2021
1Polysaccharides (Glycans)IBA
10/2020
1Dextran SulfateIBA
10/2020
1LipopolysaccharidesIBA
10/2020
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
01/2020
1Histone Deacetylases (Histone Deacetylase)IBA
01/2020
1toosendaninIBA
01/2020
1Opioid Receptors (Opioid Receptor)IBA
01/2020
1LuciferasesIBA
01/2020
1Histone Deacetylase InhibitorsIBA
01/2020
1Long Noncoding RNAIBA
01/2020
1ThioredoxinsIBA
10/2019
1ResveratrolIBA
10/2019
1Transcription Factors (Transcription Factor)IBA
09/2019
1CarcinogensIBA
08/2019
1Particulate MatterIBA
08/2019
1Docosahexaenoic AcidsIBA
04/2019
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
04/2019
1Nerve Growth Factors (Neurotrophins)IBA
04/2019
1tau Proteins (tau Protein)IBA
04/2019
1Interferon Type IIBA
01/2019
1Teniposide (VM 26)FDA Link
01/2019
1MaravirocFDA Link
01/2019
1HMGB1 Protein (HMG1)IBA
01/2019
1A-Form DNA (A-DNA)IBA
01/2019
1Topoisomerase II InhibitorsIBA
01/2019
1N-(1,4,8,11- tetraazacyclotetradecanyl- 1,4- phenylenebis(methylene))- 2- (aminomethyl)- pyridineIBA
09/2018
1CXC ChemokinesIBA
09/2018
110-N-nonylacridinium orange (NAO)IBA
01/2018
1Trastuzumab (Herceptin)FDA Link
01/2018
1Protons (Proton)IBA
01/2018
1Cisplatin (Platino)FDA LinkGeneric
11/2017
1AcidsIBA
11/2017
1Drug CombinationsIBA
11/2017
1CurcuminIBA
09/2017
1CCG 1423IBA
01/2017
1HLA-A Antigens (HLA-A)IBA
01/2017
1Circular RNAIBA
01/2017
1Blood Glucose (Blood Sugar)IBA
08/2014
1Plasminogen Activator Inhibitor 1IBA
08/2014
1CholesterolIBA
08/2014

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2022 - 09/2017
4Therapeutics
01/2022 - 09/2017
4Immunotherapy
01/2022 - 01/2019
2Radiotherapy
03/2021 - 06/2014
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2018
1Transplantation
01/2018
1Lasers (Laser)
01/2018